Challenges in treating elderly and very old cancer patients
Modern medicine has largely contributed to the remarkable increase in life expectancy in developed countries. On the other hand, this progress has also created new challenges. During the normal life span, an increasing cumulative acquisition of clonal genetic changes can be observed that predisposes to cancer and leads to the fact that cancer by itself is a predominant disease of the elderly.
In addition, the changes in age distribution in the populations with increase of the elderly pose a challenge for the care of these patients, as they need special attention and specific approaches due to the presence of comorbidities.